Element Capital Management LLC decreased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 25.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,000 shares of the financial services provider’s stock after selling 10,381 shares during the quarter. CME Group accounts for about 20.2% of Element Capital Management LLC’s holdings, making the stock its 2nd biggest position. Element Capital Management LLC’s holdings in CME Group were worth $8,269,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also modified their holdings of CME. Webster Bank N. A. raised its holdings in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the last quarter. Highline Wealth Partners LLC increased its position in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares in the last quarter. Ransom Advisory Ltd acquired a new position in shares of CME Group during the 1st quarter worth $31,000. Trifecta Capital Advisors LLC boosted its position in shares of CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 42 shares in the last quarter. Finally, Westside Investment Management Inc. grew its stake in CME Group by 105.0% in the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.
CME Group Trading Up 0.5%
Shares of CME Group stock opened at $285.04 on Monday. The firm has a market cap of $102.79 billion, a PE ratio of 27.62, a P/E/G ratio of 4.41 and a beta of 0.38. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a fifty-two week low of $222.56 and a fifty-two week high of $290.79. The business’s fifty day moving average is $267.33 and its two-hundred day moving average is $272.82.
CME Group Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s payout ratio is 48.45%.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on CME shares. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Argus reduced their target price on CME Group from $308.00 to $295.00 in a research note on Friday, October 31st. Morgan Stanley increased their target price on CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Barclays cut their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a report on Wednesday, October 8th. Finally, Raymond James Financial reduced their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $287.65.
Get Our Latest Analysis on CME
Insider Buying and Selling
In related news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard acquired 262 shares of CME Group stock in a transaction on Thursday, September 25th. The shares were bought at an average price of $265.19 per share, for a total transaction of $69,479.78. Following the purchase, the director owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders sold 14,043 shares of company stock worth $3,791,486. Corporate insiders own 0.30% of the company’s stock.
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 4 Cold-Weather Stocks to Buy as Winter Spending Heats Up
- Are Penny Stocks a Good Fit for Your Portfolio?
- Disney Stock Drops—Will Earnings Pave Way for a YouTube TV Truce?
- How to Read Stock Charts for Beginners
- Meta’s Pain May Be Your Gain: Is This a Rare Buying Window?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
